Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 24;72(12):2223-2225.
doi: 10.1136/gutjnl-2023-330706.

Targeting myeloid signalling pathways to unleash T cells

Patrick Michl  1 , Sebastian Krug  2
Affiliations
Comment

Targeting myeloid signalling pathways to unleash T cells

Patrick Michl et al. Gut. .
No abstract available

Keywords: COLORECTAL CANCER; IMMUNOTHERAPY; MACROPHAGES.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Schematic depiction of the molecular mechanisms of MS4A4A targeting on immunogenic tumour cell death. CPI, checkpoint inhibitor.
See this image and copyright information in PMC

Comment on

References

    1. Shu Y, Zheng S. The current status and prospect of immunotherapy in colorectal cancer. Clin Transl Oncol June 10, 2023. 10.1007/s12094-023-03235-0 - DOI - PubMed
    1. Ma RY, Black A, Qian BZ. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 2022;43:546–63. 10.1016/j.it.2022.04.008 - DOI - PubMed
    1. Li Y, Shen Z, Chai Z, et al. . Targeting Ms4A4A on tumour-associated Macrophages restores Cd8+ T-cell-mediated Antitumour immunity. Gut 2023;72:2307–20. 10.1136/gutjnl-2022-329147 - DOI - PMC - PubMed
    1. Sanyal R, Polyak MJ, Zuccolo J, et al. . Ms4A4A: a novel cell surface marker for M2 macrophages and plasma cells. Immunol Cell Biol 2017;95:611–9. 10.1038/icb.2017.18 - DOI - PubMed
    1. Hakimi AA, Voss MH, Kuo F, et al. . Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trial. Cancer Discov 2019;9:510–25. 10.1158/2159-8290.CD-18-0957 - DOI - PMC - PubMed